Rafferty Asset Management, LLC Sangamo Therapeutics, Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.66 - $3.67 $139,254 - $307,868	-83,888 Reduced 11.28%	660,015 $1.16 Million
Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $844,708 - $1.55 Million	304,949 Added 69.47%	743,903 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $550,394 - $823,658	128,898 Added 41.57%	438,954 $2.15 Million
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.21 $595,795 - $1.13 Million	-181,645 Reduced 36.94%	310,056 $1.28 Million
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $602,098 - $900,269	115,124 Added 30.57%	491,701 $2.86 Million
Q4 2021 Feb 10, 2022	BUY	$7.29 - $10.97 $1.29 Million - $1.95 Million	177,395 Added 89.06%	376,577 $2.82 Million
Q3 2021 Nov 10, 2021	SELL	$9.01 - $12.01 $89,027 - $118,670	-9,881 Reduced 4.73%	199,182 $1.8 Million
Q2 2021 Aug 10, 2021	SELL	$10.17 - $12.64 $810,213 - $1.01 Million	-79,667 Reduced 27.59%	209,063 $2.5 Million
Q1 2021 May 10, 2021	BUY	$10.88 - $17.05 $2.49 Million - $3.9 Million	228,869 Added 382.33%	288,730 $3.62 Million
Q4 2020 Feb 10, 2021	SELL	$9.23 - $18.18 $1.19 Million - $2.34 Million	-128,740 Reduced 68.26%	59,861 $934,000
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $1.1 Million - $1.46 Million	116,812 Added 162.72%	188,601 $1.78 Million
Q2 2020 Aug 07, 2020	BUY	$6.21 - $11.83 $350,591 - $667,874	56,456 Added 368.2%	71,789 $643,000
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $580,351 - $1.02 Million	-114,921 Reduced 88.23%	15,333 $98,000
Q4 2019 Feb 10, 2020	SELL	$8.03 - $11.7 $1.13 Million - $1.64 Million	-140,109 Reduced 51.82%	130,254 $1.09 Million
Q3 2019 Nov 14, 2019	BUY	$9.05 - $12.22 $72,273 - $97,588	7,986 Added 3.04%	270,363 $2.45 Million
Q2 2019 Aug 09, 2019	SELL	$8.75 - $13.03 $202,431 - $301,449	-23,135 Reduced 8.1%	262,377 $2.83 Million
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $2.2 Million - $3.66 Million	285,512 New	285,512 $2.72 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account